The increasing interest in insurtechs from SPACs marks the inevitable convergence between the capital markets’ current biggest craze with an area of the insurance market that had already been attracting increasing levels of funding at eye-watering multiples.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: